← FDA ENFORCEMENT
D-0418-2026Class II

Amerisource Health Services LLC

Recalling firm
Amerisource Health Services LLC
Product type
Drug
Status
Ongoing
Report date
2026-04-01
Distribution
U.S. Nationwide
Firm state
OH
Product quantity
697 cartons
Initiated by
Voluntary: Firm initiated
Reason for recall

Failed tablet specifications.

Product description

Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.

Code / lot info

Lot #1024852; Exp 9/30/2026

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.